scopadulcic acid B (Ciba-Geigy/Toyama)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namescopadulcic acid B (Ciba-Geigy/Toyama)
Drug Alias NameSDB (Ciba-Geigy/Toyama)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsStomach UlcerOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesToyama Medical and Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiba-Geigy Japan LtdToyama Medical and Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsStomach UlcerOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A